Prothrombin Time-International Normalized Ratio Predicts the Outcome of Atrial Fibrillation Patients Taking Rivaroxaban

Background: Although direct oral anticoagulants (DOACs) for patients with atrial fibrillation (AF) are considered to be safe, over or under anticoagulation and increased bleeding or thromboembolic risk are still considered individually. We aimed to investigate whether there is an association between...

Descripción completa

Detalles Bibliográficos
Autores principales: Chao, Tze-Fan, Chan, Yi-Hsin, Tsai, Pei-Chien, Lee, Hsin-Fu, Chang, Shang-Hung, Kuo, Chi-Tai, Lip, Gregory Y. H., Chen, Shih-Ann, Yeh, Yung-Hsin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775588/
https://www.ncbi.nlm.nih.gov/pubmed/36551966
http://dx.doi.org/10.3390/biomedicines10123210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775588/
https://www.ncbi.nlm.nih.gov/pubmed/36551966
http://dx.doi.org/10.3390/biomedicines10123210

Ejemplares similares